SCHEMBL866893

SCHEMBL866893

C[C@H](NN=[N+]=[N-])C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12487823 1.00 — —
SCHEMBL866892 1.00 — —
Hydrochloric Acid SCHEMBL25266273 0.98 TP53 (0.36) —
Hydrochloric Acid SCHEMBL7721977 0.98 TP53 (0.36) —
SCHEMBL16569260 0.86 MME (0.40) —
SCHEMBL31378127 0.80 — —
SCHEMBL16975026 0.78 TP53 (0.35) —
SCHEMBL16975025 0.78 TP53 (0.35) —
SCHEMBL31472581 0.78 MME (0.37) —
Hydrochloric Acid SCHEMBL7721976 0.76 TP53 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078158-A1 COMPOSITIONS COMPRISING CXCL10-DERIVED PEPTIDES AND METHODS OF USE THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2026-03-19 — — US claimed
EP-4652459-A2 CALCIUM INDEPENDENT PHOSPHATIDYLSERINE BINDING COMPOUNDS FOR DETECTING PHOSPHATIDYLSERINE POSITIVE CELLS Biolegend, Inc. (US) 2025-11-26 — — EP claimed
EP-3297670-B1 LINKER UNITS WITH TARGETING AND EFFECTOR ELEMENTS IMMUNWORK INC (TW) 2025-07-02 — — EP claimed
EP-3344659-B1 MOLECULAR CONSTRUCTS FOR PREVENTING THE FORMATION OF BLOOD CLOT AND/OR TREATING THROMBOSIS IMMUNWORK INC (TW) 2025-03-26 — — EP claimed
US-20250041439-A1 ANTIBODY-DRUG CONJUGATES SPIREA LIMITED (GB) 2025-02-06 — — US claimed
US-20240262865-A1 Calcium independent phosphatidylserine binding compounds for detecting phosphatidylserine positive cells BioLegend, Inc. 2024-08-08 — — US claimed
EP-4404974-A1 ANTIBODY-DRUG CONJUGATES Spirea Limited (GB) 2024-07-31 — — EP claimed
WO-2024155787-A2 CALCIUM INDEPENDENT PHOSPHATIDYLSERINE BINDING COMPOUNDS FOR DETECTING PHOSPHATIDYLSERINE POSITIVE CELLS ZHANG HONG (US) 2024-07-25 — — WO claimed
CN-114075588-B High-specificity cell secretion protein enrichment method 中国科学院上海有机化学研究所 2024-07-09 — — CN claimed
WO-2024086738-A2 COMPOSITIONS AND METHODS OF USE FOR INTEINS GRO BIOSCIENCES INC. (US) 2024-04-25 — — WO claimed
US-7723070-B2 Adding an desired amino acid analog to a medium containing a host cell with a vector coding for aminoacyl-tRNA synthetase and a vector coding for the polypeptide of interest; and growing the cell to produce the modified polypeptide CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2010-05-25 — — US claimed
US-20080160609-A1 Dihydrofolate reductase; site directed mutagenesis; point mutations; auxotroph host cells CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2008-07-03 — — US claimed
EP-1828780-A2 METHODS FOR PROTEOMIC PROFILING USING NON-NATURAL AMINO ACIDS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2007-09-05 — — EP claimed
WO-2007047668-A2 USE OF NON-CANONICAL AMINO ACIDS AS METABOLIC MARKERS FOR RAPIDLY-DIVIDING CELLS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2007-04-26 — — WO claimed
US-7198915-B2 Preparing modified/artificial polypeptides; mimetics CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2007-04-03 — — US claimed
US-20060216760-A1 Methods for proteomic profiling using non-natural amino acids CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-09-28 — — US claimed
WO-2006069203-A2 METHODS FOR PROTEOMIC PROFILING USING NON-NATURAL AMINO ACIDS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-06-29 — — WO claimed
US-20040058415-A1 Preparing modified/artificial polypeptides; mimetics CALIFORNIA INSTITUTE OF TECHNOLOGY 2004-03-25 — — US claimed
US-6586207-B2 Host cell is a methionine auxotroph; methionine-tRNA synthetase overexpressed in presence of analogues and absence of methionine; protein is modified dihydrofolate reductase CALIFORNIA INSTITUTE OF TECHNOLOGY 2003-07-01 — — US claimed
US-20020042097-A1 Host cell is a methionine auxotroph; methionine-tRNA synthetase overexpressed in presence of analogues and absence of methionine; protein is modified dihydrofolate reductase CALIFORNIA INSTITUTE OF TECHNOLOGY 2002-04-11 — — US claimed
Send feedback